EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up

Roberto Contieri iD, Alberto Martini iD, Marc Furrer iD, David D'Andrea iD, Francesco Claps iD, Markus von Deimling, Francesco Soria iD, Andrea Mari iD, Lorenzo Bianchi iD, Elena Tonin, Ronan Flippot, Jeremy Y C Teoh iD und 20 weitere

BJU International · 2026-06 · 137 (6) · 1058-1066

DOI: 10.1111/bju.70232 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 12.03.2026. Verfasst von Roberto Contieri und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. Hauptthemen laut MEDLINE: Cystectomy, Urinary Bladder Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop a data‐driven risk‐stratification model to identify high‐risk patients following radical cystectomy (RC) for bladder cancer and propose a risk‐adapted follow‐up (FU) schedule. Patients and Methods We performed a retrospective analysis of an individual patient data registry comprising 3196 patients with clinical T stage (cT)2–T4 N0M0 bladder cancer who underwent RC at 16 European centres (1990–2024). All treatment decisions, including the use of neoadjuvant chemotherapy, adjuvant therapy, and the FU schedule, were made at the discretion of the treating physician in accordance with the patient's preference. A Classification and Regression Tree (CART) analysis, incorporating pathological T and N stages, lymphovascular invasion (LVI), and other features, was used to stratify patients into Low‐Risk and High‐Risk groups for recurrence. The primary endpoint was recurrence‐free survival (RFS). We used a landmark analysis to evaluate the conditional risk of recurrence at 1, 2, 3, 4, and 5 years after RC.

Results

At a median FU of 81.8 months, 891 patients recurred. CART analysis identified a High‐Risk group (pathological T stage [pT]3–pT4, node‐positive disease, or pT2 with LVI) with significantly worse 5‐year RFS than the Low‐Risk group (37.8% vs 76.2%; P < 0.001). This stratification was strongly prognostic for recurrence (hazard ratio [HR] 4.29; 95% confidence interval 3.63–5.00), cancer‐specific survival (subdistribution HR 5.80), and overall survival (HR 3.04) (all P < 0.001). Landmark analysis confirmed that the elevated risk persisted up to 4 years; however, the conditional risk for event‐free patients converged after 5 years (HR 1.37; P = 0.3).

Conclusions

This study establishes a simple, pathologically derived model (pT3–4/pN+/pT2 + LVI) that effectively stratifies post‐RC patients, enabling a risk‐adapted FU strategy. Prospective evaluation of this framework is required to confirm its clinical utility, safety, and cost‐effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystectomyUrinary Bladder NeoplasmsNeoplasm Recurrence, LocalHumansRetrospective StudiesRisk AssessmentFemaleMaleAgedMiddle AgedFollow-Up StudiesNeoplasm Staging

Stichwörter der Autor:innen

Muscle invasive bladder cancerfollow‐upradical cystectomyrecurrencerisk stratification

Autor:innen und Institutionen

  • Department of Urology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Department of Urology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Department of Urology, Solothurner Spitäler AG, Olten and Solothurn, Switzerland.
  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Oncological Urology, Veneto Institute of Oncology IRCCS, Padua, Italy.

ORCID-Profile: Roberto Contieri, Alberto Martini, Marc Furrer, David D'Andrea, Francesco Claps, Francesco Soria, Andrea Mari, Lorenzo Bianchi, Jeremy Y C Teoh, Pierre-Emmanuel Desprez, Renate Pichler, Aleksander Ślusarczyk, José Daniel Subiela, Francesco Del Giudice, Antonio Amodeo, Nicola Pavan

Zitieren

APA

Contieri, R., Martini, A., Furrer, M., D'Andrea, D., Claps, F., von Deimling, M., Soria, F., Mari, A., Bianchi, L., Tonin, E., Flippot, R., Teoh, J. Y. C., Marcq, G., Desprez, P. E., Pichler, R., Ślusarczyk, A., Subiela, J. D., Del Giudice, F., Santarelli, V., …, & European Association of Urology‐Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group (2026). Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up. BJU International, 137(6), 1058-1066. https://doi.org/10.1111/bju.70232

Vancouver

Contieri R, Martini A, Furrer M, D'Andrea D, Claps F, von Deimling M, et al. Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up. BJU International. 2026;137(6):1058-1066. doi:10.1111/bju.70232

BibTeX
@article{Contieri2026,
  author = {Contieri, Roberto and Martini, Alberto and Furrer, Marc and D'Andrea, David and Claps, Francesco and von Deimling, Markus and Soria, Francesco and Mari, Andrea and Bianchi, Lorenzo and Tonin, Elena and Flippot, Ronan and Teoh, Jeremy Y C and Marcq, Gauthier and Desprez, Pierre-Emmanuel and Pichler, Renate and Ślusarczyk, Aleksander and Subiela, José Daniel and Del Giudice, Francesco and Santarelli, Valerio and Porreca, Angelo and Amodeo, Antonio and Pavan, Nicola and Simonato, Alchiede and Scilipoti, Pietro and Perdonà, Sisto and Gontero, Paolo and van Rhijn, Bas Wg and Hurle, Rodolfo and Moschini, Marco and Pradere, Benjamin and Mertens, Laura S and European Association of Urology‐Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group, European Association of Urology‐Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group},
  title = {Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up},
  journal = {BJU International},
  year = {2026},
  volume = {137},
  number = {6},
  pages = {1058--1066},
  doi = {10.1111/bju.70232}
}
Kostenlos starten →